EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Microbiota-Derived Tryptophan Metabolite Indole-3-Propionic Acid-Emerging Role in Neuroprotection

Maja Owe-Larsson iD, Dominik Drobek iD, Paulina Iwaniak iD, Renata Kloc, Ewa M Urbanska iD, Mirosława Chwil iD

Molecules · 05.09.2025 · 30 (17) · 3628

DOI: 10.3390/molecules30173628 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 05.09.2025. Verfasst von Maja Owe-Larsson und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Histology and Embryology, Center of Biostructure Research, Medical University of Warsaw, Chałubińskiego 5, 02-004 Warsaw, Poland. Hauptthemen laut MEDLINE: Tryptophan, Gastrointestinal Microbiome, Neuroprotective Agents, Indoles. Die Arbeit wurde bisher 65-mal zitiert (Crossref) und nennt 168 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Life Sciences in Lublin.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In recent years, gut–brain axis signaling has been recognized as an essential factor modifying behavior, mood, cognition, and cellular viability under physiological and pathological conditions. Consequently, the intestinal microbiome has become a potential therapeutic target in neurological and psychiatric disorders. The microbiota-derived metabolite of tryptophan (Trp), indole-3-propionic acid (IPA), was discovered to target a number of molecular processes and to impact brain function. In this review, we outline the key mechanisms by which IPA may affect neuronal activity and survival and provide an update on the evidence supporting the neuroprotective action of the compound in various experimental paradigms. Accumulating data indicates that IPA is a free radical scavenger, a ligand of aryl hydrocarbon receptors (AhR) and pregnane X receptors (PXR), and an anti-inflammatory molecule. IPA decreases the synthesis of the proinflammatory nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), tumor necrosis factor-α (TNF-α), and other cytokines, reduces the generation of the NLR family pyrin domain containing 3 (NLRP3) inflammasome, and enhances the synthesis of neurotrophic factors. Furthermore, produced in the gut, or administered orally, IPA boosts the central levels of kynurenic acid (KYNA), a neuroprotective metabolite of Trp. IPA reduces the release of proinflammatory molecules in the gut, breaking the gut–inflammation–brain vicious cycle, which otherwise leads to neuronal loss. Moreover, as a molecule that easily enters central compartment, IPA may directly impact brain function and cellular survival. Overall, the gathered data confirms neuroprotective features of IPA, and supports its potential use in high-risk populations, in order to delay the onset and ameliorate the course of neurodegenerative disorders and cognitive impairment. Clinical trials evaluating IPA as a promising therapeutic add-on, able to slow down the progress of neurodegenerative disorders such as Alzheimer’s or Parkinson’s disease and to limit the morphological and behavioral consequences of ischemic stroke, are urgently needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TryptophanGastrointestinal MicrobiomeNeuroprotective AgentsIndolesNeuroprotectionHumansAnimalsBrain

Stichwörter der Autor:innen

Alzheimer’s diseaseParkinson’s diseasearyl hydrocarbon receptorindole-3-propionic acidinflammationkynurenic acidmicrobiotaneuronal losspregnane X receptorstroketryptophan

Substanzen

TryptophanNeuroprotective AgentsIndolesindolepropionic acid

Autor:innen und Institutionen

  • Department of Histology and Embryology, Center of Biostructure Research, Medical University of Warsaw, Chałubińskiego 5, 02-004 Warsaw, Poland.
  • Chair and Department of Experimental and Clinical Pharmacology, Medical University of Lublin, Jaczewskiego 8b, 20-090 Lublin, Poland.
  • Department of Botany and Plant Physiology, University of Life Sciences in Lublin, Akademicka 15, 20-950 Lublin, Poland.

ORCID-Profile: Maja Owe-Larsson, Dominik Drobek, Paulina Iwaniak, Ewa M Urbanska, Mirosława Chwil

Förderung

  • University of Life Sciences in Lublin

Zitieren

APA

Owe-Larsson, M., Drobek, D., Iwaniak, P., Kloc, R., Urbanska, E. M., & Chwil, M. (2025). Microbiota-Derived Tryptophan Metabolite Indole-3-Propionic Acid-Emerging Role in Neuroprotection. Molecules, 30(17), 3628. https://doi.org/10.3390/molecules30173628

Vancouver

Owe-Larsson M, Drobek D, Iwaniak P, Kloc R, Urbanska EM, Chwil M. Microbiota-Derived Tryptophan Metabolite Indole-3-Propionic Acid-Emerging Role in Neuroprotection. Molecules. 2025;30(17):3628. doi:10.3390/molecules30173628

BibTeX
@article{OweLarsson2025,
  author = {Owe-Larsson, Maja and Drobek, Dominik and Iwaniak, Paulina and Kloc, Renata and Urbanska, Ewa M and Chwil, Mirosława},
  title = {Microbiota-Derived Tryptophan Metabolite Indole-3-Propionic Acid-Emerging Role in Neuroprotection},
  journal = {Molecules},
  year = {2025},
  volume = {30},
  number = {17},
  pages = {3628},
  doi = {10.3390/molecules30173628}
}
Kostenlos starten →